Diabetic Medicine · 2019 · 23 citations · 18 references
MedicineEndocrinologySurgeryAnesthesiaDiabetologyPerioperative PharmacologyDiabetes ControlDiabetes ManagementDiabetes MellitusGlucagon-like Peptide-1 Receptor AgonistsGlycemic ControlInsulin TherapyGlucagon-like Peptide 1 Receptor AgonismGlucagon-like Peptide-1 Receptor SignalingGlucagon-like PeptidesGlycemic Control After SurgeryGlycemic TargetsPerioperative Diabetes ManagementPerioperative Glucose ManagementPerioperative Glycemic Management
AIM: To test the hypothesis that the addition of a glucagon-like peptide-1 receptor agonist that can decrease glucose levels without increasing the hypoglycaemia risk will achieve appropriate glycaemic control during the peri-operative period. METHODS: We studied 70 people with Type 2 diabetes who underwent elective cardiac surgery. Participants were randomized to either an insulin-alone or an insulin plus liraglutide 0.6 mg/day group. We evaluated average M values, which indicated the proximity index of the target glucose level from day 1 to day 10. RESULTS: The average M value in the liraglutide plus insulin group was significantly lower than that in the insulin-alone group (liraglutide plus insulin 5.8 vs insulin-alone 12.3; P < 0.001). The frequency of insulin dose modification in the liraglutide plus insulin group was significantly lower than that in the insulin-alone group (odds ratio 0.19, 95% CI 0.08-0.49; P < 0.001). The frequency of hypoglycaemia in the liraglutide plus insulin group tended to be lower than that in the insulin-alone group (odds ratio 0.57, 95% CI 0.15-2.23; P = 0.21). CONCLUSIONS: The results of this study showed that the addition of low-dose liraglutide to insulin achieved lower M values than insulin alone, suggesting that the addition of low-dose liraglutide may achieve better glycaemic control during the peri-operative period. (Clinical trials registry no.: UMIN 000008003).
18
Intensive Insulin Therapy in Critically Ill Patients
Greet Van den Berghe, Pieter Wouters, Frank Weekers et al. · New England Journal of Medicine · 2001 · 10K citations · Full text
[Intensive insulin therapy in critically ill patients].
Lingcong Wang, Yanchun Wu, Jiannong Wu et al. · PubMed · 2006 · 873 citations